Kenneth M. Bahrt
2012 - SAVIENT PHARMACEUTICALS
In 2012, Kenneth M. Bahrt earned a total compensation of $1.3M as Senior Vice President and Chief Medical Officer Former Executive Officers at SAVIENT PHARMACEUTICALS, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $171,875 |
|---|---|
| Non-Equity Incentive Plan | $156,000 |
| Option Awards | $207,765 |
| Salary | $400,000 |
| Stock Awards | $339,000 |
| Other | $28,175 |
| Total | $1,302,815 |
Bahrt received $400K in salary, accounting for 31% of the total pay in 2012.
Bahrt also received $171.9K in bonus, $156K in non-equity incentive plan, $207.8K in option awards, $339K in stock awards and $28.2K in other compensation.
Rankings
In 2012, Kenneth M. Bahrt's compensation ranked 5,104th out of 11,487 executives tracked by ExecPay. In other words, Bahrt earned more than 55.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,104 out of 11,487 | 56th |
Division Manufacturing | 1,783 out of 4,253 | 58th |
Major group Chemicals And Allied Products | 429 out of 1,198 | 64th |
Industry group Drugs | 280 out of 920 | 70th |
Industry Medicinal Chemicals and Botanical Products | 3 out of 13 | 77th |
Source: SEC filing on April 29, 2013.
Bahrt's colleagues
We found four more compensation records of executives who worked with Kenneth M. Bahrt at SAVIENT PHARMACEUTICALS in 2012.